TY - JOUR
KW - opioid agonist treatment
KW - Jail
KW - Prison
KW - carceral settings
KW - United States
KW - Opioids
KW - Empirical Study
KW - Interview
KW - Qualitative Study
KW - Human
KW - Adulthood (18 yrs & older)
KW - prisons
KW - Narcotic Agonists
KW - buprenorphine
KW - opioid use disorder
KW - Drug Therapy
KW - Opiates
KW - Methadone
KW - Incarceration
KW - Substance use treatment
KW - addiction treatment
KW - article
KW - US
KW - 3383:Drug & Alcohol Rehabilitation
AU - Sachini Bandara
AU - Alene Kennedy‐Hendricks
AU - Sydney Merritt
AU - Colleen L. Barry
AU - Brendan Saloner
A1 - 
AD - Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US sbandara@jhu.edu; Center for Mental Health and Addiction Policy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US ; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US ; Bandara, Sachini,624 North Broadway Avenue,Baltimore,US,21205,Department of Mental Health, Johns Hopkins Bloomberg School of Public Health,sbandara@jhu.edu
BT - Addiction
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 12
DO - 10.1111/add.15565
IS - 12
JF - Addiction
LA - English
M1 - Journal Article
PY - 2021
SN - 0965-2140, 0965-2140
SP - 3473
EP - 3481
EP - 
T1 - Methadone and buprenorphine treatment in United States jails and prisons: Lessons from early adopters
T2 - Addiction
TI - Methadone and buprenorphine treatment in United States jails and prisons: Lessons from early adopters
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1111/add.15565
UR - https://www.proquest.com/scholarly-journals/methadone-buprenorphine-treatment-united-states/docview/2635263626/se-2?accountid=28100
VL - 116
VO - 0965-2140, 0965-2140
Y1 - 2021
Y2 - 12
ER -